Annual Neuroimmunology and Multiple Sclerosis Clinical and Research Hybrid Program: Navigating the Frontier of Autoimmune CNS Disorders: Diagnostic and Treatment Updates

Program Description: The landscape of autoimmune central nervous system (CNS) disorders is expanding at a rapid pace. The discovery of novel neural antibodies refined diagnostic criteria, and the introduction of targeted biologic therapies have revolutionized how clinicians approach these complex conditions.

This intensive 4-hour CME program provides an essential update on the diagnosis, differentiation, and management of key autoimmune CNS diseases, including Multiple Sclerosis (MS), Neuromyelitis Optica Spectrum Disorder (NMOSD), MOG Antibody-Associated Disease (MOGAD), and Autoimmune Encephalitis. Through expert-led lectures, talks on new research from UMASS Chan Medical School and discussions, participants will gain practical insights into implementing the latest diagnostic algorithms, utilizing advanced biomarkers, and tailoring personalized, evidence-based treatment strategies to optimize patient outcomes.

1. Differentiate between MS, NMOSD, MOGAD, and various autoimmune encephalitis using the latest clinical, radiographic, and serological criteria.
2. Interpret complex antibody testing panels (serum vs. CSF) to avoid common diagnostic pitfalls and misclassification.
3. Formulate individualized acute and long-term treatment plans incorporating newly approved biologic and targeted therapies.
4. Manage treatment-related risks, monitoring protocols, and long-term safety profiles in patients undergoing immunosuppressive or immunomodulatory therapy.
5. Gain knowledge about new research on the autoimmune/inflammatory CNS diseases

Active UMass Department of Neurology Employee, Neurology Residents, Fellows & Students - Free
All Other Health Professionals - $300
Physicians or nurses not affiliated with UMass - $200
UMass Alumnus - $50 

UMass Chan Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The UMass Chan designates this live activity for a maximum of 4 AMA PRA Category 1 Credits™.  Physicians should claim only credit commensurate with the extent of their participation in the activity.

Nurses: This program meets the requirements for 4.8 contact hours for nurses as specified by the Massachusetts Board of Registration in nursing (244-CMR 5.04). 

Others: Other healthcare professionals will receive a certificate that states this activity was designated for 4 AMA PRA Category 1 Credits™

Cancellation Policy

If you cancel your registration before November 25th, 2026 fee is refundable less a processing charge of $75. After that date, no refund will be given for any reason, including weather and other emergencies, substitutions are always welcome. UMass Chan Office of Continuing Medical Education and the Department of Neurology reserves the right to cancel a program at any time caused by circumstances not under its control.  Persons registered in a canceled program will be notified by email, using the email address provided when registering for the program.  There may also be changes in the program content caused by circumstances beyond the control of the Office of Continuing Medical Education.


Accessibility Statement
 
University of Massachusetts Chan Medical School is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

Beechwood Hotel
 363 Plantation St. Worcester, MA

Phone: 508-444-5850
Website

Disclosure Declarations
As a provider accredited by the ACCME, The University of Massachusetts Chan Medical School asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. 

Mitigation of Relevant Financial Relationships

All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Friday, December 18, 2026